ALLMedicine™ Hypersensitivity Pneumonitis Center
Research & Reviews 421 results
https://doi.org/10.1164/rccm.20510P20
American Journal of Respiratory and Critical Care Medicine; Janssen B, Epstein S et. al.
May 14th, 2022 - Treatment of Hypersensitivity Pneumonitis (HP).|2022|Janssen B,Epstein S,Gomez-Manjarres D,Patel DC,|
https://doi.org/10.1097/MD.0000000000029198 10.1183/23120541.00019-2016 10.3390/medicina55050161
Medicine Lin L, Zhao Y et. al.
May 6th, 2022 - By evaluating S100 calcium binding protein A9 (S100A9) and Klebs von den Lungen-6 (KL-6) expression in patients with 4 common interstitial lung diseases (ILDs), we aimed to investigate whether S100A9 or KL-6 can be of any value in the differential...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034591
BMC Pulmonary Medicine; Nili M, Singer D et. al.
Apr 24th, 2022 - Interstitial lung diseases (ILDs) include a variety of parenchymal lung diseases. The most common types of ILDs are idiopathic pulmonary fibrosis (IPF), autoimmune ILDs and hypersensitivity pneumonitis (HP). There is limited real world data on car...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008138
Transplant International : Official Journal of the Europe... Nosotti M, Leiva-Juarez M et. al.
Apr 19th, 2022 - Repeated exposure to antigens via inhalation is the primary cause of hypersensitivity pneumonitis, a form of interstitial pneumonia. The chronic form of hypersensitivity pneumonitis leads to progressive loss of respiratory function; lung transplan...
https://doi.org/10.1097/MJT.0000000000001510
American Journal of Therapeutics; Grewal US, Pande A
Apr 15th, 2022 - Rituximab Rescue in Treatment Refractory Hypersensitivity Pneumonitis.|2022|Grewal US,Pande A,|
Guidelines 3 results
https://doi.org/10.1016/j.chest.2021.03.067
Chest Fernández Pérez ER, Travis WD et. al.
Apr 19th, 2021 - The purpose of this summary is to provide a synopsis of evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variabilit...
https://doi.org/10.1016/j.chest.2021.03.066
Chest Fernández Pérez ER, Travis WD et. al.
Apr 17th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397797
American Journal of Respiratory and Critical Care Medicine; Raghu G, Remy-Jardin M et. al.
Jul 25th, 2020 - Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax.Methods: Syst...
Drugs 12 results see all →
Clinicaltrials.gov 5 results
https://clinicaltrials.gov/ct2/show/NCT04273867
Jan 27th, 2022 - The objective of this study is to administer and validate a disease-specific health related quality of life (HRQOL) survey for patients with Chronic Hypersensitivity Pneumonitis (CHP). The survey items have been developed and revised from prior qu...
https://clinicaltrials.gov/ct2/show/NCT03670576
Jul 2nd, 2021 - The overall aims of this study are Identify biomarkers and gene expression profiles that determine progressive fibrotic lung disease regardless of aetiology To prospectively assess biomarkers which predict progressive fibrosis in patients with fib...
https://clinicaltrials.gov/ct2/show/NCT02958917
May 17th, 2021 - The purpose of this study is to evaluate the potential benefits and the safety of treatment with pirfenidone compared to placebo in subjects with FHP. STUDY SUMMARY This study will include about 42 subjects at National Jewish Health. This is a "do...
https://clinicaltrials.gov/ct2/show/NCT04675619
Dec 19th, 2020 - Rationale The present data about the treatment of CHP are few and largely based on observational studies and expert opinion. It is suggested that pirfenidone may slow disease progression in cases of CHP as it has some anti-inflammatory in addition...
https://clinicaltrials.gov/ct2/show/NCT04402177
May 26th, 2020 - hypersensitivity Pneumonitis patients will be divided in two groups : non- fibrotic hypersensitivity Pneumonitis patients ( nfHP) and fibrotic hypersensitivity Pneumonitis patients ( fHP), based on HRCT findings. All patients will undergo the foll...
News 23 results
https://www.medscape.com/viewarticle/972378
Apr 19th, 2022 - Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with interstitial lung disease (ILD), new research shows....
https://www.medscape.com/viewarticle/969959
Apr 12th, 2022 - Interstitial lung diseases (ILDs) encompass a large and varied group of parenchymal lung disorders, including diseases of unknown cause, which are known as idiopathic interstitial pneumonias, as well as those associated with other diseases or envi...
https://www.onclive.com/view/overview-and-management-of-drug-induced-interstitial-lung-disease-with-novel-treatments-in-her2
Aug 24th, 2020 - Recently developed treatments for human epidermal growth factor receptor 2 (HER2)-positive (HER2+) breast cancer, lung cancers, and gastrointestinal (GI) cancers include antibody-drug conjugates (ADCs), cyclin-dependent kinase (CDK) 4/6 inhibitors...
https://www.medscape.com/viewarticle/933674
Jul 9th, 2020 - Patients with interstitial lung disease–associated pulmonary hypertension who were treated with inhaled treprostinil (Tyvaso) had significantly greater improvement in exercise capacity over 16 weeks, compared with patients who used a placebo inhal...
https://www.medscape.com/viewarticle/932183
Jun 11th, 2020 - Patients with RA have an elevated risk of interstitial lung disease (ILD), but methotrexate does not accentuate that risk and may in fact be protective, new data show. These were among key findings of a pair of studies reported at the annual Europ...